FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ

Amendment 0001 – Solicitation 75F40126R00020 The Food and Drug Administration (FDA) issues Amendment 0001 to Solicitation 75F40126R00020, Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST). Offerors are advised to review Amendment 0001 (SF-30) and all revised solicitation documents posted with this notice. The amendment includes Government responses to questions received, and revisions to the solicitation and associated attachments. The amendment package includes revised versions of the solicitation, Performance Work Statements, applicable attachments, and both clean and redline versions of revised documents to assist offerors in identifying changes. Offerors are responsible for reviewing the complete amendment package, incorporating all applicable changes into their proposals, and acknowledging receipt of the amendment in accordance with the solicitation instructions. Proposal due date remains UNCHANGED. ************************************************************************************** The U.S. Food and Drug Administration (FDA) is issuing Request for Proposal (RFP) No. 75F40126R00020 for Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) support services. The Government intends to award a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract to provide enterprise-wide Occupational Safety, Policy, Laboratory Quality, Industrial Hygiene, Information Systems, Training, and related support services across FDA headquarters and nationwide laboratory and field facilities. The IDIQ Performance Work Statement encompasses the following task areas: Program and Order Management Transition Services Occupational Safety, Policy, and Laboratory Quality Support Primary Barrier Equipment Maintenance and Certification Industrial Hygiene Support Services Information and Data Systems Support Training Development and Management The ordering period for the resulting IDIQ contract will be five (5) years from the date of award. Contract Type The Government intends to award one (1) IDIQ contract. Individual task orders may be issued as: Firm-Fixed-Price (FFP) Time-and-Materials (T&M) Labor-Hour (LH) Hybrid arrangements combining multiple pricing methodologies Contract Ceiling The maximum value of the IDIQ contract is: $14,500,000, inclusive of all ordering periods and task orders. The guaranteed minimum amount under the IDIQ is satisfied through award of the initial task order. Initial Task Order Task Order 1 will be awarded concurrently with the IDIQ award as a firm fixed price base + options. The scope consists of: CBER BSL-3 Annual Re-Verification and Decontamination Services Requirements include, but are not limited to: BSL-3 laboratory re-verification and certification support Primary barrier equipment certification validation HVAC airflow and pressure differential testing Vaporized Hydrogen Peroxide (VHP) decontamination services Biosafety compliance assessments Deficiency identification and corrective action analysis Preparation of verification reports and certification documentation. Competition Information This acquisition is being conducted pursuant to: RFO FAR Part 12 RFO FAR Part 15 RFO FAR Part 16.5 This procurement is being competed on a full and open basis unless otherwise stated by amendment. Proposal Submission Offerors shall submit proposals electronically in accordance with Section L of the solicitation. Hard-copy proposals will not be accepted. The complete solicitation package, including all attachments and pricing workbook, is available through SAM.gov. Offerors are responsible for monitoring SAM.gov for amendments, answers to questions, and other solicitation updates. Proposal Volumes Offerors shall submit: Volume 0 – Administrative Volume I – Technical Proposal Volume II – Price Proposal Volume III – Subcontracting Plan (if applicable) Evaluation Award will be made using a Best-Value Tradeoff process. Evaluation factors are: Corporate Experience Technical Approach Management Approach Past Performance Price Subcontracting Plan (for other-than-small businesses) Non-price factors, when combined, are significantly more important than price. Questions Questions regarding this solicitation must be submitted using Attachment R5, Questions and Answers Template, in accordance with the solicitation instructions no later than Tuesday, June 16, 2026. Responses to questions will be provided through solicitation amendments or SAM.gov updates as appropriate. SAM Registration Offerors must be registered in the System for Award Management (SAM) at https://sam.gov prior to award and must maintain active registration throughout contract performance.

• NAICS541690
• PSCR499

• 75F40126R00020_RFP_06.29.2026_redline.docx

  .docx169 KBNot yet available
• R7_OSIST_NCR Inventory_DRAFT.xlsx

  .xlsx68 KBNot yet available
• R3_OOSH Workstream PWS 061126.pdf

  .pdf156 KBNot yet available
• R5_OSIST_QA_Master.xlsx

  .xlsx33 KBNot yet available
• R2_CBER BSL3 Decontamination Spaces.pdf

  .pdf215 KBNot yet available
• 75F40126R00020_RFP_06.29.2026_clean.pdf

  .pdf603 KBNot yet available
• C1_OSIST_PWS_06.29.2026_clean.pdf

  .pdf325 KBNot yet available
• R1_CBER BSL3 PWS 06292026_clean.pdf

  .pdf182 KBNot yet available
• C4_FDA_Form 3398_ Non Public Agreement.pdf

  .pdf201 KBNot yet available
• 75F40126R00020_Amend 01.pdf

  .pdf164 KBNot yet available
• C2_OSIST Facility Inventory 061126.pdf

  .pdf146 KBNot yet available
• 75F40126R00020_RFP.pdf

  .pdf499 KBNot yet available
• C1_OSIST_PWS_06.29.2026_redline.docx

  .docx73 KBNot yet available
• R6_HHS Subkt Plan Template.pdf

  .pdf313 KBNot yet available
• R4 - Past Performance Questionnaire 061126.pdf

  .pdf315 KBNot yet available
• C5_FDA CTR Personnel Security Clearance.pdf

  .pdf317 KBNot yet available
• C1_OSIST_PWS 061126.pdf

  .pdf372 KBNot yet available
• R1_CBER BSL3 PWS 061126.pdf

  .pdf134 KBNot yet available
• R5_OSIST RFP Q_A Template.xlsx

  .xlsx24 KBNot yet available
• C3_OSIST_Price_Workbook.xlsx

  .xlsx44 KBNot yet available
• R1_CBER BSL3 PWS 06292026_redline.docx

  .docx52 KBNot yet available

• L. Maria Finan
  linda.finan@fda.hhs.gov2404025712
• Sheneil Green
  sheneil.green@fda.hhs.gov3017960675